Annual Retained Earnings
-$277.87 M
-$52.34 M-23.21%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual retained earnings is -$277.87 million, with the most recent change of -$52.34 million (-23.21%) on December 31, 2023.
- During the last 3 years, OVID annual retained earnings has risen by +$16.33 million (+5.55%).
- OVID annual retained earnings is now -1958.98% below its all-time high of -$13.50 million, reached on December 31, 2015.
Performance
OVID Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$295.05 M
-$14.01 M-4.98%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly retained earnings is -$295.05 million, with the most recent change of -$14.01 million (-4.98%) on September 30, 2024.
- Over the past year, OVID quarterly retained earnings has dropped by -$17.18 million (-6.18%).
- OVID quarterly retained earnings is now -721.63% below its all-time high of -$35.91 million, reached on December 31, 2016.
Performance
OVID Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
OVID Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.2% | -6.2% |
| 3 y3 years | +5.5% | -6.2% |
| 5 y5 years | -82.0% | -6.2% |
OVID Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.2% | at low | -72.2% | at low |
| 5 y | 5-year | -62.2% | +5.5% | -149.7% | at low |
| alltime | all time | -1959.0% | +5.5% | -721.6% | at low |
Ovid Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$295.05 M(+5.0%) |
| Jun 2024 | - | -$281.04 M(-2.9%) |
| Mar 2024 | - | -$289.56 M(+4.2%) |
| Dec 2023 | -$277.87 M(+23.2%) | -$277.87 M(+5.8%) |
| Sep 2023 | - | -$262.54 M(+4.5%) |
| Jun 2023 | - | -$251.29 M(+5.2%) |
| Mar 2023 | - | -$238.88 M(+5.9%) |
| Dec 2022 | -$225.53 M(+31.6%) | -$225.53 M(+5.4%) |
| Sep 2022 | - | -$214.02 M(+5.9%) |
| Jun 2022 | - | -$202.05 M(+7.8%) |
| Mar 2022 | - | -$187.47 M(+9.4%) |
| Dec 2021 | -$171.36 M(-41.8%) | -$171.36 M(+17.9%) |
| Sep 2021 | - | -$145.36 M(+8.5%) |
| Jun 2021 | - | -$133.97 M(+13.4%) |
| Mar 2021 | - | -$118.18 M(-59.8%) |
| Dec 2020 | -$294.19 M | -$294.19 M(+8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$272.16 M(+6.4%) |
| Jun 2020 | - | -$255.74 M(+9.7%) |
| Mar 2020 | - | -$233.19 M(+9.4%) |
| Dec 2019 | -$213.16 M(+39.6%) | -$213.16 M(+8.6%) |
| Sep 2019 | - | -$196.19 M(+9.3%) |
| Jun 2019 | - | -$179.55 M(+7.8%) |
| Mar 2019 | - | -$166.50 M(+9.0%) |
| Dec 2018 | -$152.70 M(+51.6%) | -$152.70 M(+9.2%) |
| Sep 2018 | - | -$139.80 M(+10.2%) |
| Jun 2018 | - | -$126.83 M(+11.4%) |
| Mar 2018 | - | -$113.90 M(+13.1%) |
| Dec 2017 | -$100.72 M(+180.5%) | -$100.72 M(+12.2%) |
| Sep 2017 | - | -$89.76 M(+11.6%) |
| Jun 2017 | - | -$80.40 M(+14.6%) |
| Mar 2017 | - | -$70.15 M(+95.3%) |
| Dec 2016 | -$35.91 M(+166.1%) | -$35.91 M |
| Dec 2015 | -$13.50 M | - |
FAQ
- What is Ovid Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Ovid Therapeutics?
- What is Ovid Therapeutics annual retained earnings year-on-year change?
- What is Ovid Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly retained earnings year-on-year change?
What is Ovid Therapeutics annual retained earnings?
The current annual retained earnings of OVID is -$277.87 M
What is the all time high annual retained earnings for Ovid Therapeutics?
Ovid Therapeutics all-time high annual retained earnings is -$13.50 M
What is Ovid Therapeutics annual retained earnings year-on-year change?
Over the past year, OVID annual retained earnings has changed by -$52.34 M (-23.21%)
What is Ovid Therapeutics quarterly retained earnings?
The current quarterly retained earnings of OVID is -$295.05 M
What is the all time high quarterly retained earnings for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly retained earnings is -$35.91 M
What is Ovid Therapeutics quarterly retained earnings year-on-year change?
Over the past year, OVID quarterly retained earnings has changed by -$17.18 M (-6.18%)